Korean J Intern Med.
2009 Dec;24(4):397-401. 10.3904/kjim.2009.24.4.397.
A Case of Tuberculous Arthritis Following the Use of Etanercept
- Affiliations
-
- 1Department of Internal Medicin, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea. choisw@uuh.ulsan.kr
- 2Department of Orthopedic Surgery, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea.
- KMID: 1776672
- DOI: http://doi.org/10.3904/kjim.2009.24.4.397
Abstract
- Etanercept is a tumor necrosis factor (TNF) inhibitor that has been used for the treatment of chronic inflammatory diseases including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Because of its immunosuppressive activity, opportunistic infections have been noted in treated patients, most notably caused by Mycobacterium tuberculosis. Tuberculosis may present in an extrapulmonary or disseminated form. Since TNF-alpha inhibitors have been used in Korea, a few cases of TNF-alpha inhibitor associated tuberculosis have been described. However, tuberculous arthritis has not been previously reported. We describe a case of tuberculous arthritis in a 57-year-old woman with rheumatoid arthritis who was treated with etanercept.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recurrent Pneumothorax after Etanercept Therapy in a Rheumatoid Arthritis Patient: A Case Report
- Development of Crohn's Disease during Etanercept Treatment in Juvenile Idiopathic Arthritis
- Rheumatoid Arthritis with Secondary Amyloidosis and Chronic Kidney Disease with a Good Response to Etanercept
- A Case of Ankylosing Spondylitis with Cricoarytenoid Arthritis
- Synovial Chondromatosis in Knee Masquerading as Tuberculosis Arthritis
